about
Forced expression of the histone demethylase Fbxl10 maintains self-renewing hematopoietic stem cellsBmi1 confers resistance to oxidative stress on hematopoietic stem cellsFbxl10 overexpression in murine hematopoietic stem cells induces leukemia involving metabolic activation and upregulation of Nsg2.β-Arrestin2 mediates the initiation and progression of myeloid leukemia.Tetraspanin 3 Is Required for the Development and Propagation of Acute Myelogenous LeukemiaThe TIF1β-HP1 system maintains transcriptional integrity of hematopoietic stem cellsA cross-sectional study on late taste disorders in survivors of allogeneic hematopoietic cell transplantation.Cytokine Profiles of Pre-Engraftment Syndrome after Single-Unit Cord Blood Transplantation for Adult Patients.Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Myelodysplastic Syndrome Harboring Trisomy 8.Different effects of lansoprazole and rabeprazole on the plasma voriconazole trough levels in allogeneic hematopoietic cell transplant recipients.Impact of hematogones on the long-term outcomes of single-unit cord blood transplantation for adult patients.Early phase mixed chimerism in bone marrow does not affect long-term outcomes of myeloablative single-unit cord blood transplantation for adult patients with hematological malignancies.Comparison of transplant outcomes from matched sibling bone marrow or peripheral blood stem cell and unrelated cord blood in patients 50 years or older.Comparison of graft-versus-host disease-free, relapse-free survival of transplantation using matched sibling donor, matched unrelated donor or unrelated cord blood after myeloablative conditioning for adult patients with hematological malignancies.Long-term persistent donor-recipient mixed chimerism without disease recurrence after myeloablative single-unit cord blood transplantation in adult acute myeloid leukemia following myelodysplastic syndrome.Breakthrough fungemia due to Candida fermentati with fks1p mutation under micafungin treatment in a cord blood transplant recipient.Effect of Granulocyte Colony-Stimulating Factor-Combined Conditioning in Cord Blood Transplantation for Myelodysplastic Syndrome and Secondary Acute Myeloid Leukemia: A Retrospective Study in Japan.Long-term outcomes of granulocyte colony-stimulating factor-combined conditioning in allogeneic hematopoietic stem cell transplantation from HLA-identical family donors for myeloid malignancies.Granulocyte colony-stimulating factor combined regimen in cord blood transplantation for acute myeloid leukemia: a nationwide retrospective analysis in Japan.The polycomb group gene product Ezh2 regulates proliferation and differentiation of murine hepatic stem/progenitor cells.Cancer progression by reprogrammed BCAA metabolism in myeloid leukaemia.Posttransplantation engraftment and safety of cord blood transplantation with grafts containing relatively low cell doses in adults.No occurrence of Pneumocystis jiroveci (carinii) pneumonia in 120 adults undergoing myeloablative unrelated cord blood transplantation.Atypical hypersensitivity to mosquito bites without natural killer cell proliferative disease in an adult patient.Multi-locus sequence analysis for identification of Achromobacter xylosoxidans from blood culture.Comparable long-term outcome of unrelated cord blood transplantation with related bone marrow or peripheral blood stem cell transplantation in patients aged 45 years or older with hematologic malignancies after myeloablative conditioning.Myeloablative unrelated cord blood transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia: comparison with other graft sources from related and unrelated donors.Unrelated cord blood transplantation after myeloablative conditioning in patients over the age of 45 years.Bacterial bloodstream infection in neutropenic adult patients after myeloablative cord blood transplantation: experience of a single institution in Japan.Hemorrhagic cystitis in adults after unrelated cord blood transplantation: a single-institution experience in Japan.Varicella-zoster virus encephalitis in a patient undergoing unrelated cord blood transplantation for myelodysplastic syndrome-overt leukemia.Fatal acute tumor lysis syndrome following intrathecal chemotherapy for acute lymphoblastic leukemia with meningeal involvement.Second myeloablative allogeneic stem cell transplantation (SCT) using cord blood for leukemia relapsed after initial allogeneic SCT.Single-unit cord blood transplantation after granulocyte colony-stimulating factor-combined myeloablative conditioning for myeloid malignancies not in remission.Unrelated cord blood transplantation after myeloablative conditioning for adult patients with refractory anemia.Early renal injury after myeloablative cord blood transplantation in adults.Impact of sex incompatibility on the outcome of single-unit cord blood transplantation for adult patients with hematological malignancies.Unrelated cord blood transplantation after myeloablative conditioning in patients with acute leukemia aged between 50 and 55 years.Risk factors and characteristics of falls among hospitalized adult patients with hematologic diseases.Monocyte subsets and their phenotypes during treatment with BCR-ABL1 tyrosine kinase inhibitors for Philadelphia chromosome-positive leukemia.
P50
Q24301301-B95C83CB-CB06-48DB-9630-15EC2CF59F50Q34273512-2485E5A7-49A7-4AA6-964E-FBF08E3FF861Q35661995-1EA77D86-B7F7-49CB-ADC6-E88F6636A823Q36140375-C3FE78C2-77EE-4C20-A475-1AE6A1343D5AQ36331291-CC50A821-8706-4761-9F00-0D6621F5EDD3Q37581605-56749B06-34F5-4B22-A80E-1782EEEBAA34Q38621055-3CC9187D-DF8C-4F78-9E71-316D4D101241Q38653488-CA10DF0D-A6DC-4E0D-9975-263D3DA8F1E2Q39253283-8B3AB698-1568-4AC8-87C3-8D392182EB79Q39479653-DBB6FD22-AF3D-437E-8D40-4651ECDC578EQ39762824-67A6537B-0BAD-42A6-B2D4-45621A59D615Q39813829-D6991F36-3028-4A34-B28B-A0293110DA0CQ39972636-45A8275D-AEED-48ED-85B0-6CDDBD630180Q40106226-07AF07BD-894A-4A61-9035-5FB0E17ED25AQ40210739-1356057D-7798-4438-99A7-D8FBFD70115CQ40446419-2BA19305-C3A1-4E4D-8B75-F0462AA11159Q40927612-5672A1B5-2936-46C3-93FB-17EF6552E30EQ41049240-766A9008-4879-4015-90EC-3BB4776B3E4EQ43057942-ED539013-7BBC-4116-9F89-8E7018202C5EQ43098140-8715A5F6-934D-42F2-B082-868DC396CF19Q43748646-89864387-2454-41C9-9B7C-4D6061324CDEQ43892930-52580B18-E29C-4347-889E-FD4A4290111EQ43899085-9729A245-B1EE-4B4F-851B-D7C2EBFE86F2Q44167740-EECEB7DE-5325-4826-BB7C-CFA1D73EDDC5Q44344042-055D422C-0C4A-42D9-BB2F-902EF9693B66Q44553469-4CE3276F-D621-4B79-AC3C-F3D7AF671178Q44613089-95551916-1606-4296-9648-5CF652A2521CQ44718475-06D238B5-CA9D-4E3D-8AD7-0965DB93C4D9Q44873549-2BB1FF35-D5BC-427E-A152-20F081704619Q44965266-67D7A424-4759-4525-AADA-62C2A4C22122Q45414104-DBCAAE4A-7534-4490-8498-9E9DDC9A1A57Q46241145-501C26C5-4F91-4908-A3A9-504979421CA6Q46257083-2109FA03-AAB6-4882-953C-0D04FF5BD4CFQ46404326-A7B58491-B599-4691-819C-C7239727629CQ46700074-93B966BC-5B64-4C0F-A73C-59D6277AC108Q46735718-38A838A4-447D-4B81-9B67-E1F237D4ADA3Q46958217-179B9236-1D7D-4AEE-A6D9-1547650C50A7Q46976426-23D7F45A-4E60-4B14-8EB7-AF17113C10B3Q47313171-A184F390-DA6D-4B41-BD92-DE1AC574CF91Q50065330-05CD08F6-64A6-47BE-8642-FB1A403A28EE
P50
description
investigador
@es
researcher
@en
name
Takaaki Konuma
@en
Takaaki Konuma
@nl
type
label
Takaaki Konuma
@en
Takaaki Konuma
@nl
prefLabel
Takaaki Konuma
@en
Takaaki Konuma
@nl
P31
P496
0000-0002-1953-8463